Please login to the form below

Not currently logged in
Email:
Password:

Peru

This page shows the latest Peru news and features for those working in and with pharma, biotech and healthcare.

CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval

CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval

Another phase 2a in Peru and Panama has also completed recruitment with 674 participants.

Latest news

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Safe from harm? Safe from harm?

    Across the world, attitudes towards healthcare decision-making vary substantially. Peru (75%), Bolivia (75%), Egypt (71%) and Chile (66%) are the countries where physicians are most likely to make treatment decisions.

  • Current development and marketing of biosimilar monoclonal antibodies in Latin America Current development and marketing of biosimilar monoclonal antibodies in Latin America

    Market. Marketed in Chile, Ecuador, Peru and Paraguay. (1). CF Recalcine (Chile). ... 5) Partnership with Human Bioscience established on July 2012 for commercialization in Colombia, Venezuela, Ecuador and Peru.}.

  • Unfolding the biosimilar landscape in Latin America Unfolding the biosimilar landscape in Latin America

    Countries like Colombia, which is on the cusp of publishing its guidelines, Venezuela, Peru or Ecuador have yet to reach a similar development status, while some smaller countries have yet to ... In Latin America, this includes countries like Brazil,

  • Positive prospects for pharma in Latin America Positive prospects for pharma in Latin America

    Espicom Business Intelligence predicts that the region's eight major markets — Brazil, Mexico, Argentina, Chile, Colombia, Cuba, Peru and Venezuela — will represent a retail value of $80bn in 2013, up from ... In Mexico, Venezuela and Peru, public

  • Interview with Roch Doliveux, UCB Interview with Roch Doliveux, UCB

    He joined the pharmaceutical industry early in his career, first at Ciba-Geigy (now Novartis) in Switzerland, Peru and France.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...